PancuroniumisareversIBLe,competitiveinhibitorofpost-synapticnicotinicacetylcholinereceptors(nAChRs)thatactsasanon-depolarizingneuromuscularjunction(NMJ)blocker.Whenusedclinically,pancuroniuminducesskeletalmusclerelaxationandactsasananesthetic.
| CasNo. | 15500-66-0 |
|---|---|
| Purity | ≥98% |
| Formula | C35H60Br2N2O4 |
| FormulaWt. | 732.67 |
| ChemicalName | 1,1"-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium)dibromide |
| IUPACName | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate;dibromide |
| Synonym | 5alpha-Androstan-3alpha,17beta-diol,2beta16beta-dipipecolinio-,dibromide,diacetate |
| MeltingPoint | 214-217C |
| Solubility | 0.1g/mlH2Oclear,colorless |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | P0252InfoSheetPDF |
|---|
JohnsonPN,MillerJ,GormleyAK.Continuous-infusionneuromuscularblockingagentsincriticallyillneonatesandchildren.Pharmacotherapy.2011Jun;31(6):609-20.PMID:21923445.
JonssonM,GurleyD,DabrowskiM,etal.Distinctpharmacologicpropertiesofneuromuscularblockingagentsonhumanneuronalnicotinicacetylcholinereceptors:apossibleexplanationforthetrain-of-fourfade.Anesthesiology.2006Sep;105(3):521-33.PMID:16931985.
MotamedC,KirovK,LieutaudT,etal.Themechanismofpancuroniumpotentiationofmivacuriumblock:useoftheisolated-armtechnique.AnesthAnalg.2000Sep;91(3):732-5.PMID:10960409.
